Clinical trials
Completed trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14,482 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 42 |
| 2001 | 84 |
| 2002 | 103 |
| 2003 | 164 |
| 2004 | 227 |
| 2005 | 280 |
| 2006 | 357 |
| 2007 | 378 |
| 2008 | 470 |
| 2009 | 524 |
| 2010 | 534 |
| 2011 | 639 |
| 2012 | 684 |
| 2013 | 675 |
| 2014 | 737 |
| 2015 | 759 |
| 2016 | 783 |
| 2017 | 881 |
| 2018 | 946 |
| 2019 | 962 |
| 2020 | 949 |
| 2021 | 948 |
| 2022 | 823 |
| 2023 | 635 |
| 2024 | 488 |
| 2025 | 249 |
| 2026 | 60 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14,482 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 468 |
| Hoffmann-La Roche | 459 |
| AstraZeneca | 318 |
| Pfizer | 313 |
| GlaxoSmithKline | 308 |
| Eli Lilly and Company | 237 |
| Bayer | 233 |
| Boehringer Ingelheim | 232 |
| Bristol-Myers Squibb | 232 |
| Sanofi | 223 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 448 |
| Neoplasms | 354 |
| Diabetes Mellitus, Type 2 | 322 |
| Carcinoma, Non-Small-Cell Lung | 321 |
| COVID-19 | 235 |
| Colorectal Neoplasms | 209 |
| Pain | 209 |
| Pulmonary Disease, Chronic Obstructive | 203 |
| HIV Infections | 201 |
| Obesity | 196 |
Trials
Showing 1 to 25 of 14,482. Each trial links to its page on Pharma Observatory.
14,382 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.